|
EVLO
|
Evelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
US
|
NASDAQ
|
|
FARN
|
Faron Pharmaceuticals Oy
|
UK
|
LSE
|
|
FATE
|
Fate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FBIOP
|
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
US
|
NASDAQ
|
|
FENC
|
Fennec Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen Inc
|
MX
|
MX
|
|
FGEN
|
FibroGen, Inc
|
US
|
NASDAQ
|
|
FGHQF
|
Frontage Holdings Corporation
|
US
|
US
|
|
FIXX
|
Homology Medicines, Inc.
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FPMI
|
Fluoropharma Medical Inc
|
US
|
OTC
|
|
FREQ
|
Frequency Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FWP
|
Forward Pharma A/S
|
US
|
NASDAQ
|
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
|
GBIM
|
Globeimmune Cm
|
US
|
OTC
|
|
GDTC
|
CytoMed Therapeutics Limited Ordinary Shares
|
US
|
US
|
|
GERN
|
Geron Corporation
|
US
|
NASDAQ
|